Abstract
Bifunctional chelating agents are important in the development of site-specific radiopharmaceuticals for diagnosis and therapy of cancer. Recently. our Laboratory has developed a new dithio-diphosphine (P2S2COOH)-based bifunctional chelating agent [1]. Its coupling to biologically important molecules such as peptide analogs and steroids have been investigated in detail (Scheme I). The intermediate compound P2S2 phosphine hydride 3 was synthesized as described in scheme 1 [1]. The coupling of 3 with steroids such as 2/4 amino estrone/estrodiol and the peptide analog GlyGlyOEt was undertaken using peptide the coupling reagent HBTU in the presence of triethylamine. Furthermore. the P2S2GlyGlyOEt phosphine hydride was formylated using formaldehyde in ethanol and then complexed with a Re(V) precursor to yield the new Re(V) bioconjugate 5. This offers a potential mute to label biologically active peptides with radionuclides such as Tc-99m and Re-186/188 for use in cancm diagnosis and/or therapy.